Key facts
- This page summarizes Roberto Cuca's Form 4 filing for TELA Bio, Inc. (TELA).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Feb 2026, 20:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Tax liability
Tax liability
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.
Footnote F2
Includes 1,079 shares acquired under the Company's employee stock purchase plan on each of July 31, 2025 and January 30, 2026.
Footnote F3
Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
Footnote F4
The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.